Antigen recognized by IgG Fab

The term "Antigen recognized by IgG Fab" is a generic functional description rather than a specific molecular entity. It refers to any molecule (antigen) that is specifically bound by the Fragment antigen-binding (Fab) region of an Immunoglobulin G (IgG) antibody. The Fab region contains the variable domains (VH and VL) that form the paratope, allowing for high-affinity recognition of a specific epitope on the target antigen. In drug development, this phrase is often used as a placeholder in databases when the specific target of a Fab-based therapeutic is not explicitly named or when referring to the general mechanism of antibody-antigen interaction. Examples of specific antigens targeted by therapeutic Fabs include Vascular Endothelial Growth Factor (VEGF) by Ranibizumab and Glycoprotein IIb/IIIa by Abciximab. Because it does not identify a unique protein, it is considered an incorrect or generic target name for structured biological data. Therapeutic Fabs are primarily used to neutralize soluble factors or block cell-surface receptors without inducing Fc-mediated effector functions like antibody-dependent cellular cytotoxicity (ADCC).

Other names

Antibody targetFab-binding antigenEpitope-containing moleculeImmunogen

Binding of the Fab fragment to a specific epitope on the antigen to neutralize its biological activity, block receptor-ligand interactions, or facilitate the clearance of toxins.